Art
J-GLOBAL ID:201802267216261406   Reference number:18A0359499

Red ginseng extracts attenuate skin inflammation in atopic dermatitis through p70 ribosomal protein S6 kinase activation

紅参抽出物はp70リボソーム蛋白質S6キナーゼ活性化を介してアトピー性皮膚炎における皮膚炎症を減弱する
Author (9):
Material:
Volume: 136  Issue:Page: 9-15  Publication year: 2018 
JST Material Number: U0667A  ISSN: 1347-8613  Document type: Article
Article type: 原著論文  Country of issue: Netherlands (NLD)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0359499&from=J-GLOBAL&jstjournalNo=U0667A") }}
JST classification (2):
JST classification
Category name(code) classified by JST.
Basic research of pharmacology of crude drugs  ,  Basic dermatology 
Reference (24):
  • Siraganian RP. Mast cell signal transduction from the high-affinity IgE receptor. Curr Opin Immunol. 2003;15:639-646.
  • Kinet J-P. The high-affinity I g E receptor (FcεRI): from physiology to pathology. Annu Rev Immunol. 1999;17:931-972.
  • Kawakami T, Galli SJ. Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol. 2002;2:773-786.
  • Harir N, Friedbichler K, Sonneck K, et al. Oncogenic kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade 2008;112: 2463-2473.
  • Lusková P, Dráber P. Modulation of the Fcepsilon receptor I signaling by tyrosine kinase inhibitors: search for therapeutic targets of inflammatory and allergy diseases. Curr Pharm Des. 2004;10:1727-1737.
more...

Return to Previous Page